MedPath

Clinical trial on pain related to joints

Phase 1
Conditions
Health Condition 1: M109- Gout, unspecified
Registration Number
CTRI/2024/05/067777
Lead Sponsor
Kerala Ayurveda Limited Head
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Willing to give informed consent.

2.Otherwise healthy Indian male/ female volunteer aged between 18-65 years.

3.Must be able to adhere to the study visit schedule and other protocol requirements.

4.Willing to complete the questionnaires for the total duration of 45 days.

5.History or currently suffering from joint pain (due to uric acid).

6.Agree not to use any medications for Osteoarthritis during the study duration.

7.Willing to avoid usage of pain relievers like Ibuprofen, Acetaminophen or any other NSAIDs etc. during the study duration.

8.Agree not to use any medication (prescription and over the counter), including vitamins and minerals, during the course of this study.

Exclusion Criteria

1.Pregnant or Breast feeding.

2.Inability to provide voluntary consent.

3.Patients with preexisting severe systemic disease necessitating long term medication.

4.Evidence of significant uncontrolled co-morbid disease which in the investigators opinion would jeopardize patient participation.

5.Any clinically significant medical history, medical finding or an ongoing medical or psychiatric condition exists which in the opinion of the Investigator could jeopardize the safety of the subject, impact validity of the study results or interfere with the completion of study according to the protocol.

6.Use of any diuretics

7.History of cancer, including solid tumors hematologic malignancies and carcinoma in situ

8.Use of any anti-psychotic drugs for one week prior to Baseline.

9.Subjects who abuse drugs or alcohol drug screening not required.

10.Use of any investigational medication within 4 weeks prior to start of study drug.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Percentage change in the uric acid levels <br/ ><br>2.Percentage Improvement in the pain due to uric acid accumulation (Sandhi shola) assessed through VAS <br/ ><br>3.Percentage Change in the joint swelling (Sandhi sopha) assessed by the Investigator and By taking prakriti of the subjects. <br/ ><br>4.Percentage Change in Gout impact using GAQ2.0 Questionnaire <br/ ><br>Timepoint: Day and Day 42
Secondary Outcome Measures
NameTimeMethod
Assessment of Change in Quality of life using WHOQOL -100Timepoint: Day and Day 42
Âİ Copyright 2025. All Rights Reserved by MedPath